Jakob Schwalbe Lohmann works with IPR within the following industries:
Jakob Schwalbe Lohmann
European Patent Attorney, Partner, UPC Representative
MSc Molecular Biology, PhD Medicine
Jakob is part of our Life Science & Chemistry team and has extensive expert knowledge within a wide range of technologies, especially CRISPR, stem cells, radiopharmaceuticals (Theranostics), antibodies, vaccines, food, feed, plants and nutrition. In addition, Jakob has experience with seed and bacteria depositing.
He works with all aspects of intellectual property rights (IPR), including drafting and international prosecution of patent applications. He advises clients in the field of computer‑implemented inventions (software/artificial intelligence (AI)) within the life‑science space, as well as on commercialization and patent strategy, including on how to implement patent strategies in a simple and effective manner. He also gives lectures within these unique areas.
Due to his diverse range of clients, including international companies, SMEs, universities, hospitals and investors, he has a unique understanding of IP from different perspectives. To further strengthen his business understanding, Jakob has completed an education at Copenhagen Business School (CBS) relating to business development within the life science area. Furthermore, Jakob is registered as a representative before the Unified Patent Court (UPC).
He is a co-inventor on several patents and author on a number of scientific papers. He has also conducted research relating to insights on the effectiveness of third-party observations at the European Patent Office (EPO) and the Danish Patent and Trademark Office and contributed to the book “Antibody Patenting: A Practitioner’s Guide to Drafting, Prosecution and Enforcement of Antibody Patents (Second Edition)” edited by Jürgen Meier and Oswin Ridderbusch.
Jakob joined Plougmann Vingtoft in 2008.
